882672-05-1 Usage
General Description
6-Bromo-2-chloroquinazoline is a chemical compound with the molecular formula C8H5BrClN2. It is a heterocyclic aromatic molecule that contains a quinazoline ring with bromine and chlorine substituents. 6-Bromo-2-chloroquinazoline has applications in various fields, including pharmaceuticals, agrochemicals, and materials science. It is commonly used as a building block in the synthesis of pharmaceuticals and other organic compounds. Additionally, 6-Bromo-2-chloroquinazoline is also used as a research reagent in the laboratory for studying chemical reactions and developing new compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 882672-05-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,2,6,7 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 882672-05:
(8*8)+(7*8)+(6*2)+(5*6)+(4*7)+(3*2)+(2*0)+(1*5)=201
201 % 10 = 1
So 882672-05-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H4BrClN2/c9-6-1-2-7-5(3-6)4-11-8(10)12-7/h1-4H
882672-05-1Relevant articles and documents
Deuterium kinase selective inhibitor
-
Paragraph 0061; 0067, (2017/11/30)
The invention relates to a deuterium kinase selective inhibitor and provides a compound shown as formula (I), a stereoisomer, a tautomer or pharmaceutically acceptable salt thereof and the application of the compound used as FGFR4 kinase selective inhibit
Inhibitors of the fibroblast growth factor receptor
-
Page/Page column 38; 39, (2017/08/01)
Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of FGFR-4.
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
-
Paragraph 0131; 0132, (2015/07/22)
Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of FGFR-4.